Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: Results from the SEARCH database

BJU International

Volumn 104, Issue 10, 2009, Pages 1452-1456

  Moreira, Daniel M ^a,b   Jayachandran, Jayakrishnan ^a,b   Presti Jr , Joseph C ^d   Aronson, William J ^b,e   Terris, Martha K ^b   Kane, Christopher J ^f   Amling, Christopher L ^g   Stephenson, Andrew J ^h   Freedland, Stephen J ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f UCSD MEDICAL CENTER   (United States)

^g Alabama   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Disease free survival; Nomograms; Progression; Prostate cancer; Prostatectomy; PSA; Radiotherapy; Validation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DATA BASE; DISEASE COURSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SALVAGE THERAPY; SURVIVAL TIME; VALIDATION STUDY;

AGED; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 72349090269     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08623.x     Document Type: Article

References (19)

1. Klein EA, Bianco FJ, Serio AM et al. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. J Urol 2008 179 : 2212 2216
2. Trock BJ, Han M, Freedland SJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008 299 : 2760 2769
3. Stephenson AJ, Scardino PT, Kattan MW et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007 25 : 2035 2041
4. Kattan MW. Validating a prognostic model. Cancer 2006 107 : 2523 2524
5. Hamilton RJ, Aronson WJ, Presti JC et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 2007 110 : 2202 2209
6. Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 2003 61 : 365 369
7. Stephenson AJ, Shariat SF, Zelefsky MJ et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004 291 : 1325 1332
8. Freedland SJ, Humphreys EB, Mangold LA et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005 294 : 433 439
9. Harrell FE Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA 1982 247 : 2543 2546
10. Buskirk SJ, Pisansky TM, Schild SE et al. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006 176 : 985 990
11. Song DY, Thompson TL, Ramakrishnan V et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002 60 : 281 287
12. Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2001 19 : 1030 1039
13. Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR. Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database. Urol Oncol 2008 26 : 271 275
14. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998 90 : 766 771
15. Graefen M, Karakiewicz PI, Cagiannos I et al. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol 2002 7 : 141 146
16. D'Amico AV, Whittington R, Malkowicz SB et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999 17 : 168 172
17. Schroeck FR, Aronson WJ, Presti et al. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int 2009 103 : 603 608
18. Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys 2007 67 : 1074 1081
19. Jereczek-Fossa BA, Orecchia R. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. Radiother Oncol 2007 84 : 197 215